ArticleBMC infectious diseases2026
Human papillomavirus vaccine uptake and associated factors among schoolgirls in Sululta and Chancho towns, Central Ethiopia: a cross-sectional study.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundCervical cancer is the second leading cause of cancer incidence and mortality among women in Ethiopia. The introduction of the human papillomavirus (HPV) vaccine is expected to substantially reduce the burden of the disease. However, evidence regarding HPV vaccine uptake in Ethiopia remains limited. This study aimed to assess the level of HPV vaccination uptake and its associated factors among adolescent schoolgirls in Sululta and Chancho towns, Oromia Region, Central Ethiopia.
methodsAn institution-based cross-sectional study was conducted among 416 adolescent schoolgirls (225 from Sululta and 191 from Chancho) selected using a simple random sampling technique; 400 participants completed the study (response rate = 96%). Data were entered, coded, and cleaned using Epi Info version 7.2.5 and analyzed with SPSS version 25. Descriptive statistics were used to summarize proportions and percentages. Bivariate and multivariable logistic regression analyses were performed to identify factors associated with HPV vaccine uptake.
resultsThe overall HPV vaccine uptake was 63.3% (95% CI: 59%–68%), comprising 32.8% partially vaccinated and 30.5% fully vaccinated schoolgirls. Factors significantly associated with vaccination uptake included knowledge or information about HPV and the HPV vaccine (AOR = 12.953; 95% CI: 3.696–45.392), mothers’ educational level (primary education: AOR = 1.888; 95% CI: 1.036–3.442; secondary education: AOR = 2.911; 95% CI: 1.215–6.971; higher education: AOR = 5.182; 95% CI: 1.153–23.291), and being 16 years of age (AOR = 6.76; 95% CI: 1.241–36.878). Maternal knowledge and education level remained significant predictors of HPV vaccine uptake in multivariable analysis.
conclusionHPV vaccination coverage among the study participants was relatively high compared to previous reports from other regions of Ethiopia. Age, maternal education, and knowledge about HPV infection and vaccination were significant predictors of vaccine uptake. Key barriers to vaccination included concerns about potential side effects, limited awareness of the vaccination schedule, and negative attitudes toward vaccination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.